Literature DB >> 25466378

Adverse outcome pathway (AOP) development I: strategies and principles.

Daniel L Villeneuve1, Doug Crump2, Natàlia Garcia-Reyero2, Markus Hecker2, Thomas H Hutchinson2, Carlie A LaLone3, Brigitte Landesmann2, Teresa Lettieri2, Sharon Munn2, Malgorzata Nepelska2, Mary Ann Ottinger2, Lucia Vergauwen2, Maurice Whelan2.   

Abstract

An adverse outcome pathway (AOP) is a conceptual framework that organizes existing knowledge concerning biologically plausible, and empirically supported, links between molecular-level perturbation of a biological system and an adverse outcome at a level of biological organization of regulatory relevance. Systematic organization of information into AOP frameworks has potential to improve regulatory decision-making through greater integration and more meaningful use of mechanistic data. However, for the scientific community to collectively develop a useful AOP knowledgebase that encompasses toxicological contexts of concern to human health and ecological risk assessment, it is critical that AOPs be developed in accordance with a consistent set of core principles. Based on the experiences and scientific discourse among a group of AOP practitioners, we propose a set of five fundamental principles that guide AOP development: (1) AOPs are not chemical specific; (2) AOPs are modular and composed of reusable components-notably key events (KEs) and key event relationships (KERs); (3) an individual AOP, composed of a single sequence of KEs and KERs, is a pragmatic unit of AOP development and evaluation; (4) networks composed of multiple AOPs that share common KEs and KERs are likely to be the functional unit of prediction for most real-world scenarios; and (5) AOPs are living documents that will evolve over time as new knowledge is generated. The goal of the present article was to introduce some strategies for AOP development and detail the rationale behind these 5 key principles. Consideration of these principles addresses many of the current uncertainties regarding the AOP framework and its application and is intended to foster greater consistency in AOP development. Published by Oxford University Press on behalf of the Society of Toxicological 2014. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Keywords:  adverse outcome pathway; extrapolation; knowledgebase; predictive toxicology; regulatory toxicology

Mesh:

Year:  2014        PMID: 25466378      PMCID: PMC4318923          DOI: 10.1093/toxsci/kfu199

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  22 in total

Review 1.  Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

Authors:  Gerald T Ankley; Richard S Bennett; Russell J Erickson; Dale J Hoff; Michael W Hornung; Rodney D Johnson; David R Mount; John W Nichols; Christine L Russom; Patricia K Schmieder; Jose A Serrrano; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Toxicol Chem       Date:  2010-03       Impact factor: 3.742

2.  Use of trout liver slices to enhance mechanistic interpretation of estrogen receptor binding for cost-effective prioritization of chemicals within large inventories.

Authors:  Patricia K Schmieder; Mark A Tapper; Jeffrey S Denny; Richard C Kolanczyk; Barbara R Sheedy; Tala R Henry; Gilman D Veith
Journal:  Environ Sci Technol       Date:  2004-12-01       Impact factor: 9.028

3.  Meeting the scientific needs of ecological risk assessment in a regulatory context.

Authors:  Steven P Bradbury; Tom C J Feijtel; Cornelis J Van Leeuwen
Journal:  Environ Sci Technol       Date:  2004-12-01       Impact factor: 9.028

Review 4.  Thyroid disrupting chemicals: mechanisms and mixtures.

Authors:  Kevin M Crofton
Journal:  Int J Androl       Date:  2008-01-22

5.  Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies.

Authors:  David C Volz; Scott Belanger; Michelle Embry; Stephanie Padilla; Hans Sanderson; Kristin Schirmer; Stefan Scholz; Daniel Villeneuve
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

6.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA).

Authors:  Knut Erik Tollefsen; Stefan Scholz; Mark T Cronin; Stephen W Edwards; Joop de Knecht; Kevin Crofton; Natalia Garcia-Reyero; Thomas Hartung; Andrew Worth; Grace Patlewicz
Journal:  Regul Toxicol Pharmacol       Date:  2014-09-27       Impact factor: 3.271

Review 7.  Development of an adverse outcome pathway for acetylcholinesterase inhibition leading to acute mortality.

Authors:  Christine L Russom; Carlie A LaLone; Daniel L Villeneuve; Gerald T Ankley
Journal:  Environ Toxicol Chem       Date:  2014-08-25       Impact factor: 3.742

8.  Toxicity testing in the 21st century: a vision and a strategy.

Authors:  Daniel Krewski; Daniel Acosta; Melvin Andersen; Henry Anderson; John C Bailar; Kim Boekelheide; Robert Brent; Gail Charnley; Vivian G Cheung; Sidney Green; Karl T Kelsey; Nancy I Kerkvliet; Abby A Li; Lawrence McCray; Otto Meyer; Reid D Patterson; William Pennie; Robert A Scala; Gina M Solomon; Martin Stephens; James Yager; Lauren Zeise
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-02       Impact factor: 6.393

9.  Endocrine disrupting chemicals in fish: developing exposure indicators and predictive models of effects based on mechanism of action.

Authors:  Gerald T Ankley; David C Bencic; Michael S Breen; Timothy W Collette; Rory B Conolly; Nancy D Denslow; Stephen W Edwards; Drew R Ekman; Natalia Garcia-Reyero; Kathleen M Jensen; James M Lazorchak; Dalma Martinović; David H Miller; Edward J Perkins; Edward F Orlando; Daniel L Villeneuve; Rong-Lin Wang; Karen H Watanabe
Journal:  Aquat Toxicol       Date:  2009-02-10       Impact factor: 4.964

Review 10.  IPCS framework for analyzing the relevance of a noncancer mode of action for humans.

Authors:  Alan R Boobis; John E Doe; Barbara Heinrich-Hirsch; M E Bette Meek; Sharon Munn; Mathuros Ruchirawat; Josef Schlatter; Jennifer Seed; Carolyn Vickers
Journal:  Crit Rev Toxicol       Date:  2008       Impact factor: 5.635

View more
  143 in total

Review 1.  Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways.

Authors:  Daniel L Villeneuve; Brigitte Landesmann; Paola Allavena; Noah Ashley; Anna Bal-Price; Emanuela Corsini; Sabina Halappanavar; Tracy Hussell; Debra Laskin; Toby Lawrence; David Nikolic-Paterson; Marc Pallardy; Alicia Paini; Raymond Pieters; Robert Roth; Florianne Tschudi-Monnet
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

2.  Rapid effects of the aromatase inhibitor fadrozole on steroid production and gene expression in the ovary of female fathead minnows (Pimephales promelas).

Authors:  Anthony L Schroeder; Gerald T Ankley; Tanwir Habib; Natalia Garcia-Reyero; Barbara L Escalon; Kathleen M Jensen; Michael D Kahl; Elizabeth J Durhan; Elizabeth A Makynen; Jenna E Cavallin; Dalma Martinovic-Weigelt; Edward J Perkins; Daniel L Villeneuve
Journal:  Gen Comp Endocrinol       Date:  2017-07-21       Impact factor: 2.822

3.  Adverse outcome pathway development II: best practices.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

Review 4.  Progress in data interoperability to support computational toxicology and chemical safety evaluation.

Authors:  Sean Watford; Stephen Edwards; Michelle Angrish; Richard S Judson; Katie Paul Friedman
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-09       Impact factor: 4.219

5.  Linking Mitochondrial Dysfunction to Organismal and Population Health in the Context of Environmental Pollutants: Progress and Considerations for Mitochondrial Adverse Outcome Pathways.

Authors:  David A Dreier; Danielle F Mello; Joel N Meyer; Christopher J Martyniuk
Journal:  Environ Toxicol Chem       Date:  2019-08       Impact factor: 3.742

6.  A proposal for creating a taxonomy of chemical interactions using concepts from the aggregate exposure and adverse outcome pathways.

Authors:  Paul Price; Jeremy Leonard
Journal:  Curr Opin Toxicol       Date:  2019-08-01

Review 7.  Practical approaches to adverse outcome pathway development and weight-of-evidence evaluation as illustrated by ecotoxicological case studies.

Authors:  Kellie A Fay; Daniel L Villeneuve; Carlie A LaLone; You Song; Knut Erik Tollefsen; Gerald T Ankley
Journal:  Environ Toxicol Chem       Date:  2017-03-31       Impact factor: 3.742

8.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

Review 9.  Ecotoxico-lipidomics: An emerging concept to understand chemical-metabolic relationships in comparative fish models.

Authors:  David A Dreier; John A Bowden; Juan J Aristizabal-Henao; Nancy D Denslow; Christopher J Martyniuk
Journal:  Comp Biochem Physiol Part D Genomics Proteomics       Date:  2020-09-11       Impact factor: 2.674

10.  Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.

Authors:  Michelle M Angrish; Charlene A McQueen; Elaine Cohen-Hubal; Maribel Bruno; Yue Ge; Brian N Chorley
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.